Amani Therapeutics
PrivateLast Round
Series A
Mar 23, 2026
Total Funding Raised
$25.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Amani Therapeutics is a biotechnology company developing AM-01, a fixed-dose combination therapy for serious neuropsychiatric disorders including treatment-resistant schizophrenia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amani Therapeutics Comparables
Compare Amani Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tortugas Neuroscience | 77% | |
| LB Pharmaceuticals | 76% | |
| Terran Biosciences | 73% |
Amani Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2026 |
Amani Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RTW Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
$25M round completed.
Amani Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amani Therapeutics's valuation, stock price, and market status.
Is Amani Therapeutics a public or private company?
Amani Therapeutics is a private company.
What is the current stock price of Amani Therapeutics?
Amani Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Amani Therapeutics worth (valuation)?
Valuation information for Amani Therapeutics is not publicly available.
Can I buy Amani Therapeutics stock?
Amani Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amani Therapeutics's last funding round?
Amani Therapeutics's most recent funding round was Series A on March 23, 2026.
Who are the main investors in Amani Therapeutics?
Key investors in Amani Therapeutics include RTW Investments.
Will Amani Therapeutics IPO soon?
No public IPO plans have been announced for Amani Therapeutics.
How can I track Amani Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amani Therapeutics's secondary market activity and sign up for updates.